A Phase IIb clinical trial of ADX-102 in dry eye disease.

Trial Profile

A Phase IIb clinical trial of ADX-102 in dry eye disease.

Planning
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Reproxalap (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2017 According to an Aldeyra Therapeutics media release, results from this trial are expected to be announced in the second half of 2018.
    • 13 Sep 2017 New trial record
    • 12 Sep 2017 According to an Aldeyra Therapeutics media release, company is planning to initiate this study in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top